Address
:
[go:
up one dir
,
main page
]
Include Form
Remove Scripts
Session Cookies
Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q53295989)
Watch
English
Alzheimer's disease: Moving towards a vaccine.
scientific article published in July 2008
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
title
Alzheimer's disease: Moving towards a vaccine.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
main subject
Alzheimer's disease
1 reference
based on heuristic
inferred from title
author
David M. Holtzman
series ordinal
1
object named as
David M Holtzman
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
language of work or name
English
0 references
publication date
1 July 2008
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
published in
Nature
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
volume
454
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
issue
7203
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
page(s)
418-420
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
cites work
Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
21 January 2018
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Active and passive immunotherapy for neurodegenerative disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2F454418A
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/454418A
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
Dimensions Publication ID
1027815516
0 references
PubMed publication ID
18650906
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18650906
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/18650906
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit